Sign up to save your podcasts
Or
Share Understanding Blood-Based Biomarkers in Alzheimer Disease
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Understanding Blood-Based Biomarkers in Alzheimer Disease
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease.
Purchase Annual Meeting On Demand to get access to the recordings and the ability to claim CME through March 1, 2026.
Disclosures can be found at Neurology.org.
View all episodes
By American Academy of Neurology
4.7
272272 ratings
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease.
Purchase Annual Meeting On Demand to get access to the recordings and the ability to claim CME through March 1, 2026.
Disclosures can be found at Neurology.org.
More shows like Neurology® Podcast
View all
JAMA Editors' Summary
129 Listeners
NEJM This Week
314 Listeners
Practical Neurology Podcast
44 Listeners
JAMA Clinical Reviews
488 Listeners
The Curbsiders Internal Medicine Podcast
3,314 Listeners
JAMA Neurology Author Interviews
14 Listeners
Core IM | Internal Medicine Podcast
1,090 Listeners
Neurology Today in 5
22 Listeners
Annals On Call Podcast
184 Listeners
The Clinical Problem Solvers
508 Listeners
Neurology Minute
132 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
321 Listeners
Neurology Exam Prep Podcast
182 Listeners
The Curious Clinicians
362 Listeners
Continuum Audio
77 Listeners